These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3841435)

  • 1. [Regulation of the activity of the blood kinin system as a method for the pathogenetic therapy of pulmonary tuberculosis].
    Priĭmak AA; Makinskiĭ AI
    Vrach Delo; 1985 Oct; (10):95-7. PubMed ID: 3841435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of the blood kinin system in the course of the reparation processes in tuberculosis].
    Makinskiĭ AI; Solov'eva IP
    Vrach Delo; 1986 Dec; (12):78-80. PubMed ID: 3548065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications for using antikinin preparations and blood kinin system activators in the combined treatment of pulmonary tuberculosis].
    Makinskiĭ AI
    Probl Tuberk; 1981 Oct; (10):33-7. PubMed ID: 7312848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action of andekalin, an activator of the blood kinin system, on the course of experimental tuberculosis].
    Makinskiĭ AI; Solov'eva IP; Braude VI
    Probl Tuberk; 1985; (5):59-63. PubMed ID: 3840259
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood kinin system in scleroderma treated with andecalin].
    Sbitneva EP; Beliakov NV; Kuznetsov VA
    Vestn Dermatol Venerol; 1979 May; (5):26-9. PubMed ID: 452674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
    Keleberda KIa; Svistunova AS; Kaminskaia GO; Kordonskaia VM
    Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of prodectin in pulmonary tuberculosis].
    Safarov RN; Makinskiĭ AI
    Vrach Delo; 1981 Nov; (11):83-4. PubMed ID: 7342450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood proteolytic systems in patients with pulmonary tuberculosis].
    Khudzik LB; Morozova TI
    Probl Tuberk; 1994; (5):56-8. PubMed ID: 7870735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of kinin system inhibitors and stimulants on the course of tuberculosis and the healing processes in an experiment].
    Puzik VI; Uvarova OA; Zemskova ZS; Kaminskaia GO; Gedymin LE
    Probl Tuberk; 1983 May; (5):52-6. PubMed ID: 6191323
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of antikinin preparations as pathogenetic agents in the overall therapy of tuberculosis].
    Makinskiĭ AI
    Probl Tuberk; 1978 Apr; (4):70-4. PubMed ID: 349551
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of prodectin on the activity of the blood kallikrein-kinin system in diffuse toxic goiter].
    Oleĭnik VA; Matiashina GI
    Probl Endokrinol (Mosk); 1986; 32(4):7-10. PubMed ID: 3639497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of andekalin in treating diabetic microangiopathies].
    Surovikina MS; Semenova LV
    Probl Endokrinol (Mosk); 1986; 32(5):10-4. PubMed ID: 3641273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feasibility of pathogenetic treatment of pulmonary tuberculosis patients with and without complicating diseases].
    Keleberda KIa; Khudiakova RV; Svistunova AS; Ashirov AA
    Probl Tuberk; 1983 Apr; (4):20-5. PubMed ID: 6866963
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
    Matiashina GI
    Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action of the antikinin preparation pyridinolcarbamate on the development of experimental tuberculosis].
    Makinskiĭ AI; Solov'eva IP; Braude VI
    Probl Tuberk; 1984 May; (5):60-5. PubMed ID: 6739480
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of conjunctival biomicroscopy and liquid-crystal thermography in diabetes mellitus in children and adolescents].
    Krishchenko OP; Sarana VA; la Stuliĭ ; Terebkova IV; Kolotova LI
    Probl Endokrinol (Mosk); 1989; 35(5):37-40. PubMed ID: 2587523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Theoretical grounds of a trend of pathogenetic therapy of tuberculosis].
    Puzik VI; Makinskiĭ AI
    Probl Tuberk; 1976 Sep; (9):57-63. PubMed ID: 64980
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of antikinin agents on the course of experimental myocarditis].
    Surovikina MS; Odinokova VA; Paleev NR; Gurevich MA; Iankovskaia MO
    Kardiologiia; 1976 Sep; 16(9):84-9. PubMed ID: 189119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
    Solov'eva IP; Makinskiĭ AI
    Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
    [No Abstract]   [Full Text] [Related]  

  • 20. [An experimental model of depletion of the blood kallikrein-kinin system].
    Shumilov SP
    Biull Eksp Biol Med; 1993 Oct; 116(10):343-4. PubMed ID: 8117942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.